Compugen Ltd (CGEN)

[surf1944]

7:10AM Compugen announces the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma (CGEN) 4.41 : In recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, demonstrated broad expression in human multiple myeloma tumor cells, including drug resistant and aggressive primary tumor cell lines.